@CedillaTx (@cedillatx) profile picture

A New Dimension in Precision Oncology

Joined May 2018
Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)Photo by @CedillaTx (@cedillatx)
Cedilla is fundraising for @NOCC_National in support of the hundreds of thousands of women living with #ovariancancer in the United States. Cedilla is dedicated to changing the course of cancer, and we are proud to contribute to the Coalition’s work. https://nitter.cf/t.co/9n1dRbIgT2
Did you know that #conditionalinhibitors could bring reduced off-target toxicity and side effects? Because they address functionally relevant conditions, our candidates modulate the pathogenic function of their targets rather than the physiologic function. https://nitter.cf/t.co/986bNdTEHu
#HappyHalloween from #CedillaTx - we're wishing you a safe, happy, and not too scary holiday!
1
1
We had a wonderful Halloween in the office, featuring wizardry from Sandra and Veronique!
For nearly 5 years, Senior Scientist I Jordan Bartlebaugh has been researching targets, advancing assays, testing drug combinations, and more at #CedillaTx – in fact, she was the first scientist we hired! Outside of work, you can find her reading or playing darts. #MeetCedilla
1
At Cedilla, one of our core values is to be Authentic. We believe that by bringing our best selves to the office, we all can do our best work. Authenticity is an essential part of the Cedilla culture, supporting our team’s work to bring a new dimension to #precisiononcology.
What are #ConditionalInhibitors? These modulatory therapeutics are being advanced by #CedillaTx for the treatment of cancer. Under certain conditions relevant to tumor growth, these inhibitors are enabled to modulate oncological targets. Learn more: https://nitter.cf/t.co/986bNeaHJu
Cedilla CEO Sandra Glucksmann will be speaking at the @LongwoodLeaders Fall Webconference this week. Sandra and other biotech CEOs will discuss the next wave of targeted therapies. Learn more: https://nitter.cf/t.co/UtMSxfPB4V
2
We are thrilled to announce two recent promotions at #CedillaTx! Congratulations to Tingwei Tsai, promoted to Principal Data Engineer, and Brandon Nicolay, promoted to Senior Director, Pharmacology. Their hard work and dedication to Cedilla’s mission is invaluable for our team!
2
Happy #LaborDay to everyone on the Cedilla team! Thank you all for your dedication and hard work towards our mission to develop targeted medicines to change the course of cancer. Have a wonderful holiday!
2
Did you know that August 24 is U.S. National #Waffle Day? On Wednesday, the Cedilla team gathered to recharge and enjoy a variety of delicious waffles. Our hard-working team recognizes the importance of taking a break to enjoy the sweet things in life. #biotech #companyculture
2
One of #CedillaTx's lead programs is focused on disrupting the hyperactivated state of #TEAD, a key inhibitor of the Hippo signaling pathway. The Hippo pathway is often dysregulated in certain cancers, and our program is aimed at restoring normal function to the pathway.
2
#DYK sequence & structure have been the standard lens to understand protein function for the past 60 years? #CedillaTx is pioneering a new era of precision oncology by focusing on cellular context and orchestration of protein function to develop #conditionalinhibitors.
1
The #cedillatx team is excited to partner with @Northeastern to welcome our co-ops, Emily Fu and Lucia Maragno. Emily is supporting our Biomolecular Sciences team and Lucia is supporting our Biology team. They will be here until the end of Dec. and we are thrilled to have them!
2
Our scientists are investigating the intricate design of the cellular context and how it impacts protein dysregulation. The insights from our research are key in identifying drivers of disease and developing #conditionalinhibitors that could change the course of #cancer therapy.
1
The #CedillaTx team had a wonderful summer outing this week at Thompson Island, a short ferry ride away in the Boston Harbor! Our afternoon was filled with lawn games, walking trails and a cookout lunch. Thrilled to spend this time with our Cedilla colleagues!
2
Our scientists are investigating the intricate design of the cellular context and how it impacts protein dysregulation. The insights from our research are key in identifying drivers of disease and developing #conditionalinhibitors that could change the course of #cancer therapy.
1
Happy #July4th from the #CedillaTx team. We wish everyone a happy and healthy holiday weekend!
1
Teach & Learn is a key pillar of the #CedillaTx culture. This month, we came together to learn about and celebrate #PrideMonth!
2
Our #conditionalinhibitors only modulate targets when they’re in a unique context, allowing us to modulate targets’ pathogenic function, decrease off-target toxicity & develop profiles suitable for combination therapy. Learn more: https://nitter.cf/t.co/fvH9Wq4abk #CedillaTx
3